Non-profitUnited Statesfamilyheart.org
Also known as FH Foundation and The FH Foundation.
None yet. When a new project in the record names Family Heart Foundation as owner, partner or investor, it shows here.
Oral macrocyclic peptide enlicitide (20 mg) lowers LDL-C ~56–59% at week 24 in Phase 3 trials; approved as adjunct to diet and exercise for adults with hypercholesterolemia, including HeFH.
